Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US7601354B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Jun 15, 2006 |
| Grant date | Oct 13, 2009 |
| Priority date | — |
| Expiry date | Feb 28, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is based on the discovery that the administration of at least one immunoconjugate and at least one chemotherapeutic agent provides an unexpectedly superior treatment for cancer. The present invention is directed to compositions comprising at least one immunoconjugate and at least one chemotherapeutic agent and to methods of treating cancer using at least one immunoconjugate and at least one chemotherapeutic agent. The present invention also provides methods of modulating the growth of selected cell populations, such as cancer cells, by administering a therapeutically effective amount of at least one chemotherapeutic agent and at least one immunoconjugate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.